WuXi AppTec (OTCMKTS:WUXAY) Trading 7.8% Higher – What’s Next?

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY)’s stock price shot up 7.8% during trading on Tuesday . The company traded as high as $25.3350 and last traded at $25.3350. 1,500 shares traded hands during trading, a decline of 31% from the average session volume of 2,181 shares. The stock had previously closed at $23.51.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised WuXi AppTec from a “hold” rating to a “strong-buy” rating in a research report on Friday, August 7th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company. According to MarketBeat.com, WuXi AppTec presently has an average rating of “Strong Buy”.

WuXi AppTec Trading Down 1.0%

The company’s fifty day simple moving average is $23.31 and its 200-day simple moving average is $18.64.

About WuXi AppTec

WuXi AppTec is a global pharmaceutical and biotechnology services company that provides research, development, and manufacturing support to pharmaceutical, biotechnology, and medical device companies. Its integrated platform is designed to help customers discover, develop, test, and manufacture medicines and healthcare products.

The company’s services include small-molecule drug discovery and development, laboratory testing, clinical research support, and pharmaceutical manufacturing. WuXi AppTec also provides capabilities in biologics, cell and gene therapies, medical devices, and other advanced therapeutic areas, serving customers across multiple stages of the product-development process.

Founded in 2000, WuXi AppTec is headquartered in Shanghai, China, and operates through a global network of research, testing, and manufacturing facilities in China, the United States, Europe, and other international markets.